Overview
Founded in 2020, Vigil Neuroscience is a rapidly growing startup biotechnology company taking innovative approaches to treating both rare and common diseases of the central nervous system. We focus on the research and development of both small and large molecule drugs that can positively modulate neuroinflammation through modifying the biology of the principal innate immune system cell of the CNS, the microglia. We are patient-focused and strive to discover, research, develop and clinically test innovative medicines to improve the lives of those suffering from debilitating and lethal neurological conditions.